2024
DOI: 10.1039/d3md00696d
|View full text |Cite
|
Sign up to set email alerts
|

Structure-based virtual screening of unbiased and RNA-focused libraries to identify new ligands for the HCV IRES model system

Elisabeth Kallert,
Laura Almena Rodriguez,
Jan-Åke Husmann
et al.

Abstract: Targeting RNA including viral RNAs with small molecules is an emerging field. The hepatitis C virus internal ribosome entry site (HCV IRES) is a potential target for translation inhibitor development...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 88 publications
0
1
0
Order By: Relevance
“…RNA plays a fundamental role in many biological processes. Consequently, RNA has gained significant interest as a potential drug, such as with antisense oligonucleotide therapeutics, , but also as a target for small molecules. To target RNA structures, multiple high-throughput screening (HTS) assays or fragment screenings have been developed, while structure-based approaches are still rare. One frequently mentioned challenge or even limitation of RNA targeting approaches via small molecules is the low chemical diversity of RNA, which makes it difficult to find ligands with a high affinity and selectivity. Still, with only four nucleobases (Figure ) compared to 20 canonical amino acids in proteins, RNA is able to form complex folds, and its chemical diversity is not only enhanced by over 170 known RNA modifications, but also by adapting to the local environment through different protomeric and tautomeric states of the nucleobases. While X-ray structures do not include proton information, protonation states and tautomers can be deduced from only nucleobase geometries and atom distances.…”
Section: Introductionmentioning
confidence: 99%
“…RNA plays a fundamental role in many biological processes. Consequently, RNA has gained significant interest as a potential drug, such as with antisense oligonucleotide therapeutics, , but also as a target for small molecules. To target RNA structures, multiple high-throughput screening (HTS) assays or fragment screenings have been developed, while structure-based approaches are still rare. One frequently mentioned challenge or even limitation of RNA targeting approaches via small molecules is the low chemical diversity of RNA, which makes it difficult to find ligands with a high affinity and selectivity. Still, with only four nucleobases (Figure ) compared to 20 canonical amino acids in proteins, RNA is able to form complex folds, and its chemical diversity is not only enhanced by over 170 known RNA modifications, but also by adapting to the local environment through different protomeric and tautomeric states of the nucleobases. While X-ray structures do not include proton information, protonation states and tautomers can be deduced from only nucleobase geometries and atom distances.…”
Section: Introductionmentioning
confidence: 99%